Cooper, Samuel E. http://orcid.org/0000-0001-9563-1750
van Dis, Eva A. M.
Hagenaars, Muriel A.
Krypotos, Angelos-Miltiadis
Nemeroff, Charles B.
Lissek, Shmuel
Engelhard, Iris M.
Dunsmoor, Joseph E. http://orcid.org/0000-0002-5448-6873
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (F32 MH129136, R01 MH122387)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (453-15-005)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
National Science Foundation (1844792)
Article History
Received: 25 February 2022
Revised: 11 April 2022
Accepted: 15 April 2022
First Online: 30 April 2022
Competing interests
: CBN has received research support from NIH; he has served as a consultant for ANeuroTech (division of Anima BV), Signant Health, Magstim, Inc., Navitor Pharmaceuticals, Inc., Intra-Cellular Therapies, Inc., EMA Wellness, Acadia Pharmaceuticals, Sage, BioXcel Therapeutics, Silo Pharma, XW Pharma, Neuritek, Engrail Therapeutics, Corcept Therapeutics Pharmaceuticals Company, SK Life Science, Alfasigma, Pasithea Therapeutic Corp., EcoR1; he has served on scientific advisory boards for the ANeuroTech (division of Anima BV), Brain and Behavior Research Foundation (BBRF), Anxiety and Depression Association of America (ADAA), Skyland Trail, Signant Health, Laureate Institute for Brain Research (LIBR), Inc., Magnolia CNS, Heading Health, TRUUST Neuroimaging, Pasithea Therapeutic Corp.; he is a stockholder in Xhale, Seattle Genetics, Antares, BI Gen Holdings, Inc., Corcept Therapeutics Pharmaceuticals Company, EMA Wellness, TRUUST Neuroimaging; he serves on the board of directors for Gratitude America, ADAA, Xhale Smart, Inc., Lucy Scientific Discovery, Inc; and he holds patents on a method and devices for transdermal delivery of lithium (patent 6,375,990B1) and a method of assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters by ex vivo assay (patent 7,148,027B2). The other authors report no financial relationships with commercial interests.